Les toxidermies paroxystiques graves.

Paquet, Philippe; Flagothier, Caroline; Pierard, Claudine; Jacob, E.; Damas, Pierre; Heymans, O.; Pierard, Gérald

Download

Article (Scientific journals)

Les toxidermies paroxystiques graves.

Paquet, Philippe; Flagothier, Caroline; Pierard, Claudine et al.

2004 • In Revue Médicale de Liège, 59 (5), p. 286-92

Peer reviewed

Permalink
https://hdl.handle.net/2268/11128

PubMed
15264578

Files (1)Send to Details Statistics Bibliography Similar publications

Files

Full Text

TOXIDERMIE.pdf

Publisher postprint (1.02 MB)

Download

All documents in ORBi are protected by a user license.

Send to

RIS BibTex APA Chicago Permalink X Linkedin

Details

Keywords :

Acute Disease; Diagnosis, Differential; Epidermal Necrolysis, Toxic/pathology; Humans; Prognosis; Syndrome

Abstract :

[en] Some drug reactions showing cutaneous expression exhibit a paroxysmal course. These diseases encompass the toxic epidermal necrolysis, the drug hypersensitivity syndrome, and the acute generalized exanthematic pustulosis. These syndromes are associated with dismal outcome. They represent medical emergencies needing hospitalization in specialized care units.

Disciplines :

Dermatology

Author, co-author :

Paquet, Philippe ; Centre Hospitalier Universitaire de Liège - CHU > Dermatopathologie

Flagothier, Caroline ; Centre Hospitalier Universitaire de Liège - CHU > Dermatologie

Pierard, Claudine ; Centre Hospitalier Universitaire de Liège - CHU > Dermatopathologie

Jacob, E.; Centre Hospitalier Universitaire de Liège - CHU

Damas, Pierre ; Centre Hospitalier Universitaire de Liège - CHU > Soins intensifs

Heymans, O.

Pierard, Gérald ; Centre Hospitalier Universitaire de Liège - CHU > Dermatopathologie

Language :

French

Title :

Les toxidermies paroxystiques graves.

Alternative titles :

[en] Severe paroxysmal drug eruptions.

Publication date :

2004

Journal title :

Revue Médicale de Liège

ISSN :

0370-629X

eISSN :

2566-1566

Publisher :

Université de Liège. Revue Médicale de Liège, Liège, Belgium

Volume :

Issue :

Pages :

286-92

Peer reviewed :

Peer reviewed

Available on ORBi :

since 14 April 2009

Statistics

Number of views

272 (9 by ULiège)

Number of downloads

1140 (2 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

Bibliography

Revuz J.- Introduction to severe drug reactions. Sem Cut Med Surg, 1996, 15, 215-216.
Fumal I, Sriha B, Paquet P, et al.- Les toxidermies iatrogènes, une rançon de la quête de la santé. Rev Med Liège, 2001, 56, 583-591.
Fritsch PO, Sidoroff A.- Drug-induced Stevens-Johnson syndrome / Toxic epidermal necrolysis. Am J Clin Dermatol 2000, 1, 349-360.
Paquet P.- La nécrolyse épidermique toxique: du diagnostic au traitement. Rev Med Liège 1992, 47, 145-153.
Piérard-Franchimont C, Piérard GE.- La nécrolyse épidermique toxique et la fasciite nécrosante: deux urgences graves à présentation dermatologique. Rev Med Liège, 1997, 52, 593-597.
Vittorio C, Muglia J.- Anticonvulsant hypersensitivity syndrome. Arch Intern Med 1995, 155, 2285-2290.
Carroll M, Yueng-Yuc C, Esterly N, et al.- Drug-induced hypersensitivity syndrome in pediatric patients. Pediatrics 2001, 108, 485-493.
Machet L, Martin L, Vaillant L.- Pustulose exanthématique aiguë généralisée. Ann Dermatol Venereol 2001, 128, 73-79.
Sidoroff A, Halevy S, Bouwes JN, et al.- Acute generalized exanthematous pustulosis (AGEP). A clinical reaction pattern. J Cutan Pathol 2001, 28, 113-119.
Cohen A, Cagnano E, Halevy S.- Acute generalized exanthematous pustulosis mimicking toxic epidermal necrolysis. Int J Dermatol 2001, 40, 458-461.
Brandenburg V, Kurts C, Eitner F, et al.- Acute reversible renal failure in acute generalized exanthematous pustulosis. Nephrol Dial Transplant 2002, 17, 1857-1858.
Paquet P.- Les médicaments responsables de la nécrolyse épidermique toxique (syndrome de Lyell). Thérapie 1993, 48, 133-139.
Knowles SR, Shapiro LE, Shear NH.- Anticonvulsant hypersensitivity syndrome: incidence, prevention and management. Drug Saf 1999, 21, 489-501.
Paquet P, Arrese JE, Greimers R, et al.- Eruptive speckled melanocytic naevi following drug-induced toxic epidermal necrolysis. Eur J Dermatol 1995, 5, 379-382.
Haus C, Paquet P, Maréchal-Courtois C.- Le traitement ophtalmologique du syndrome de Lyell. Rev Med Liège 1993, 48, 395-400.
Paquet P, Jacob E, Damas P, et al.- Recurrent fatal drug-induced toxic epidermal necrolysis (Lyell's syndrome) after putative b-lactam cross-reactivity: case report and scrutiny of antibiotic imputability. Crit Care Med 2002, 30, 2580-2583.
Paquet P, Piérard GE, Quatresooz P.- Novel treatments for drug-induced toxic epidermal necrolysis. Curr Pharm Design, sous presse.
Criton S, Devi K, Sridevi PK, et al.- Toxic epidermal necrolysis - a retrospective study. Int J Dermatol 1997, 36, 923-925.
Stables GI, Lever RS.- Toxic epidermal necrolysis and systemic corticosteroids. Br J Dermatol 1993, 128, 357.
Tegelberg-Stassen MJAM, Van Ioten WA, Baart de la Faille H.- Management of non-staphylococcal toxic epidermal necrolysis: follow-up study of 16 case histories. Dermatologica 1990, 180, 124-129.
Rzany B, Schmitt H, Schöpf E.- Toxic epidermal necrolysis in patients receiving glucocorticoids. Acta Dermatol Venereol 1991, 71, 171-172.
Guibal F, Bastuji-Garin S, Chosidow O, et al.- Characteristics of toxic epidermal necrolysis in patients undergoing long-term glucocorticoid therapy. Arch Dermatol 1995, 131, 669-672.
Halebian P, Corder V, Madden M, et al.- Improved burn center survival of patients with toxic epidermal necrolysis managed without corticosteroids. Ann Surg 1986, 204, 503-512.
Kelemen JJ, Cioffi W, McManus w, et al.- Burn center care for patients with toxic epidermal necrolysis. J Am Coll Surg 1995, 180, 273-278.
Viard I, Wehrli P, Bullani R, et al.- Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin. Science 1998, 282, 490-493.
Stella M, Cassano P, Bollero D, et al.- Toxic epidermal necrolysis treated with intravenous high-dose immunoglobulins : our experience. Dermatology 2001, 203, 45-49.
Paquet P, Jacob E, Damas P, Piérard GE.- Treatment of drug-induced toxic epidermal necrolysis (Lyell's syndrome) with intravenous human immunoglobulins. Burns 2001, 27, 652-655.
Tristani-Firouzi P, Ptersen M, Saffle JR, et al.- Treatment of toxic epidermal necrolysis with intravenous immunoglobulin in children. J Am Acad Dermatol 2002, 47, 548-552.
Prins C, Kerdel FA, Padilla RS, et al.- Treatment of toxic epidermal necrolysis with high-dose intravenous immunoglobulin. Arch Dermatol 2003, 139, 26-32.
Bachot N, Revuz J, Roujeau JC.- Intravenous immunoglobulin treatment for Stevens-Johnson syndrome and toxic epidermal necrolysis. Arch Dermatol 2003, 139, 33-36.
Trent JT, Kirsner RS, Romanelli P, et al.- Analysis of intravenous immunoglobulin for the treatment of toxic epidermal necrolysis using SCORTEN. Arch Dermatol 2003, 139, 39-43.
Tas S, Simonart T.- Management of drug rash with eosinophilia and systemic symptoms (DRESS syndrome) : an update. Dermatology 2003, 206, 353-356.